StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Next report date, year-over-year trend, and recent quarter history.
5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.
Factor scoring needs Finnhub-supplied fundamentals — Finnhub returned no fundamental metrics for this ticker. Common for ETFs, foreign filers without US listing depth, recent IPOs, and thinly-traded OTC names.
6-factor scoring with sector-relative rank. Updated daily.
Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-11 | $0.14 | $0.13 | -7.93% | 0.0M |
| 05-12 | $0.12 | $0.13 | +8.95% | 0.0M |
| 05-13 | $0.13 | $0.12 | -4.70% | 0.0M |
| 05-14 | $0.11 | $0.12 | +8.91% | 0.1M |
| 05-15 | $0.11 | $0.11 | +4.37% | 0.0M |
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
| Metric | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 | Annual 2024 2024-12-31 |
|---|---|---|---|---|
Revenue | $3.56M | $2.68M | $1.43M | $6.77M |
Operating Income | $-12.32M | $-7.56M | $-3.66M | $-38.63M |
Net Income | $-7.34M | $-506.00K | $3.97M | $-53.36M |
EPS (Diluted) | $-0.19 | $-0.01 | $0.11 | $-2.61 |
Total Assets | $65.70M | $42.04M | $50.11M | $63.20M |
Total Liabilities | $58.84M | $30.61M | $34.99M | $55.85M |
Cash & Equivalents | $405.00K | $169.00K | $88.00K | $678.00K |
Free Cash Flow OCF − CapEx | $-7.11M | $-3.63M | $-3.38M | $-18.44M |
Shares Outstanding | 41.54M | 41.54M | 41.54M | 29.87M |
These are published opinions from external sell-side analysts — not Stonvex recommendations. Ratings may change without notice, may conflict with each other, and may be wrong. Not investment advice.
Consensus aggregated from publicly disclosed sell-side analyst ratings. Stonvex is not a registered investment advisor and does not endorse any of the ratings shown. Past analyst ratings do not predict future price movements.
PROPHASE LABS INC